Grants and Contributions:
Title:
Business Development project for creation of Cannabis Standard Formulary
Agreement Number:
914180
Agreement Value:
$50,000.00
Agreement Date:
Sep 3, 2018 - Feb 28, 2019
Description:
Cannabis Standard will be an evidence-based medical cannabis formulary based on best available evidence and expert advice. Cannabis Standard includes the formulary with detailed specifications, digital platform that produces the ACMPR-required Medical Document, and registry to capture real-world patient outcomes (quality of life and productivity data).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5J 1R7
Reference Number:
172-2018-2019-Q4-914180
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819455601
Recipient Type:
For-profit organization
Recipient's Legal Name:
Reformulary Group Inc.
Federal Riding Name:
Spadina--Fort York
Federal Riding Number:
35101
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
51121